Aditxt, Inc. Debt Instrument, Interest Rate, Stated Percentage
Aditxt, Inc. (ADTX) had Debt Instrument, Interest Rate, Stated Percentage of 50.00% as of 2023-04-18, per its 10-Q filed 2023-08-14.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentInterestRateStatedPercentage · last filed 2023-08-14
- 2023-04-18: Debt Instrument, Interest Rate, Stated Percentage 50.00%.
- 2021-01-25: Debt Instrument, Interest Rate, Stated Percentage 105.00%.
- 2018-04-12: Debt Instrument, Interest Rate, Stated Percentage 4.00%.
| Period end | Debt Instrument, Interest Rate, Stated Percentage |
|---|---|
| 2023-04-18 | 50.00% 10-Q · filed 2023-08-14 |
| 2021-01-25 | 105.00% 10-K · filed 2022-03-31 |
| 2018-04-12 | 4.00% 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |